Skip to main content
AlzChem Group AG logo

AlzChem Group AG — Investor Relations & Filings

Ticker · ACT ISIN · DE000A2YNT30 LEI · 8945004EL7WZK3ERG181 F Manufacturing
Open in API
Filings indexed 414 across all filing types
Latest filing 2019-04-23 Board/Management Inform…
Country DE Germany
Listing F ACT

About AlzChem Group AG

https://www.alzchem.com/en

AlzChem Group AG is a globally active, vertically integrated specialty chemicals company focused on NCN (Nitrogen-Carbon-Nitrogen) chemistry. Its production chain is based on raw materials such as calcium carbide and calcium cyanamide, from which it develops a wide range of products. The company serves diverse markets including human and animal nutrition, pharmaceuticals, agriculture, metallurgy, renewable energy, and automotive. Key products include high-purity creatine for dietary supplements (Creapure®), feed additives for animal nutrition (Creamino®), and high-purity guanidine salts used as intermediates for pharmaceutical and diagnostic applications, such as PCR tests. AlzChem also offers custom synthesis services and is a market leader in many of its business segments.

Recent filings

Filing Released Lang Actions
Datum:23.04.2019
Board/Management Information Classification · 100% confidence The document is a comprehensive report from AlzChem Group AG covering the fiscal period from July 1, 2018, to December 31, 2018. It includes the 'Bericht des Aufsichtsrats' (Supervisory Board Report), 'Konzernlagebericht' (Group Management Report), details on corporate governance, audit results, and financial highlights. This structure is characteristic of an Annual Report (or in this case, a short fiscal year report equivalent to an Annual Report). It is not a mere announcement (RPA) as it contains detailed financial and operational disclosures.
2019-04-23 German
AlzChem Group AG: CEO Ulli Seibel leaves the company at the end of 2019 after ten successful years
Board/Management Information Classification · 100% confidence The document is a short news announcement dated April 3, 2019, titled "AlzChem Group AG: CEO Ulli Seibel leaves the company at the end of 2019 after ten successful years." It explicitly details the departure of the CEO and includes quotes from the CEO and the Chairman of the Supervisory Board. This content directly relates to changes in senior management. Based on the definitions, this fits the 'Board/Management Information' category (MANG). The document length is short (2812 chars), but it is the primary announcement itself, not an announcement *about* a report, so the RPA/RNS rule does not apply here.
2019-04-03 English
AlzChem Group AG: CEO Ulli Seibel will not renew his contract after the end of 2019
Board/Management Information Classification · 100% confidence The document is a short, ad-hoc announcement dated April 3, 2019, disclosing that the CEO, Ulli Seibel, will not renew his contract after the end of 2019. This directly relates to changes in senior management. Based on the definitions, this fits the 'Board/Management Information' category (Code: MANG). It is not an earnings release, a full report, or a proxy statement.
2019-04-03 English
AlzChem Group AG: Bekanntmachung der Einberufung zur Hauptversammlung am 14.05.2019 in Munchen mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information Classification · 99% confidence The document is titled 'Einladung zur ordentlichen Hauptversammlung' (Invitation to the Annual General Meeting) and explicitly mentions the date and location of the AGM (May 14, 2019, in Munich). The agenda items (Tagesordnung) detail proposals for shareholder votes, including the approval of financial statements, dividend distribution, discharge of management/supervisory boards, and significant capital structure changes (share consolidation/reduction). This content is the core material distributed to shareholders in preparation for the Annual General Meeting. Therefore, it aligns perfectly with the definition of AGM Information (AGM-R). It is not a general regulatory filing (RNS) because it is highly specific to the AGM, nor is it a proxy statement (PSI) which typically solicits votes, although it contains the necessary information for voting.
2019-04-03 German
AlzChem Group AG: clear growth in sales and earnings in calendar year 2018
Earnings Release Classification · 100% confidence The document is a news release disseminated via DGAP-News, titled "AlzChem Group AG: clear growth in sales and earnings in calendar year 2018." It explicitly reports key financial metrics for the calendar year 2018 (Sales, EBITDA, Net Income) and provides a forecast for 2019. This content structure—summarizing period results and outlook—is characteristic of an Earnings Release (ER). Although it mentions the Annual Report 2018 is available for download, the document itself is the announcement summarizing those results, not the full report (which would typically be classified as 10-K if it were the full filing, but this is a press release format). Since it focuses on the initial announcement of period results, ER is the most appropriate classification. The length (6905 chars) is substantial but the format is clearly a news announcement, not a comprehensive regulatory filing like a 10-K. H2 2018
2019-03-29 English
Annual financial report 2018
Annual Report Classification · 100% confidence The document is titled 'ANNUAL REPORT 2018' and contains comprehensive sections including a Management Board interview, Supervisory Board report, Group Management Report, and Consolidated Financial Statements. It provides detailed financial performance data for the fiscal period, fitting the definition of an Annual Report (10-K). H2 2018
2019-03-28 German

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.